The NCL 2024-25 Prescribing Quality Scheme (PQS) will be launched ahead of individual practice visits.  

The 2024-25 PQS invests in and promotes high-quality, safe, clinically effective, cost-efficient, evidence-based prescribing and is intended to support the implementation of national and local guidance. 

This event will discuss entry criteria, individual markers in more detail, scheme monitoring, resource materials, ScriptSwitch® messages, submission dates and award payment.

If you have any questions, contact Jyoti.Gupta@nhs.net in the NCL Medicines Optimisation team.